KRONOS BIO INC (KRON) Stock Income Statement
NASDAQ:KRON - Nasdaq - US50107A1043 - Common Stock - Currency: USD
| 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 9.85M | 6.29M | 0.00 | 0.00 | 0.00 | |||
| Operating Expenses | 73.28M | 123.49M | 137.12M | 151.40M | 58.04M | |||
| Research and Development | 45.60M | 81.20M | 90.65M | 109.59M | 38.96M | |||
| Selling, General, and Administrative Expenses | 27.68M | 42.29M | 46.47M | 41.80M | 19.07M | |||
| Operating Income | -63.43M | -117.20M | -137.12M | -151.40M | -58.04M | |||
| Interest Income/Expense | 6.81M | 9.40M | 3.91M | 320.00K | -30.40M | |||
| Non Recurring Items | -29.45M | -4.88M | N/A | N/A | N/A | |||
| Income Before Taxes | -86.08M | -112.67M | -133.20M | -151.08M | -88.44M | |||
| Net Income | -86.08M | -112.67M | -133.20M | -151.08M | -88.44M | |||
| EBITDA | -61.72M | -115.06M | -134.85M | -149.42M | -57.20M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -1.43 | -1.95 | -2.37 | -2.76 | -1.64 | |||
| Non GAAP EPS | N/A | -1.86 | -2.37 | -2.75 | N/A | |||
| Statistics | ||||||||
| Profit Margin | -874.08% | -1791.87% | N/A | N/A | N/A | |||
| Operating Profit Margin | -644.11% | -1863.88% | N/A | N/A | N/A | |||
All data in USD